Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

912 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention.
Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, Takayama M, Kitagawa K, Nishikawa M, Miyazaki S, Ikeda Y, Nakamura M, Saito S; PRASFIT-Elective Investigators. Isshiki T, et al. Among authors: takayama m. Circ J. 2014;78(12):2926-34. doi: 10.1253/circj.cj-14-0266. Epub 2014 Oct 21. Circ J. 2014. PMID: 25342212 Free article. Clinical Trial.
Optimal cutoff value of P2Y12 reaction units to prevent major adverse cardiovascular events in the acute periprocedural period: post-hoc analysis of the randomized PRASFIT-ACS study.
Nakamura M, Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, Takayama M, Kitagawa K, Ikeda Y, Saito S. Nakamura M, et al. Among authors: takayama m. Int J Cardiol. 2015 Mar 1;182:541-8. doi: 10.1016/j.ijcard.2015.01.026. Epub 2015 Jan 8. Int J Cardiol. 2015. PMID: 25679803 Free article.
Effects of CYP2C19 allelic variants on inhibition of platelet aggregation and major adverse cardiovascular events in Japanese patients with acute coronary syndrome: The PRASFIT-ACS study.
Ogawa H, Isshiki T, Kimura T, Yokoi H, Nanto S, Takayama M, Kitagawa K, Nishikawa M, Miyazaki S, Ikeda Y, Nakamura M, Tanaka Y, Saito S. Ogawa H, et al. Among authors: takayama m. J Cardiol. 2016 Jul;68(1):29-36. doi: 10.1016/j.jjcc.2015.07.019. Epub 2015 Oct 29. J Cardiol. 2016. PMID: 26521100 Free article. Clinical Trial.
Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism　- First Results From the SALUTE Trial.
Aonuma K, Yamasaki H, Nakamura M, Ootomo T, Takayama M, Ando K, Hirao K, Morino Y, Hayashida K, Kusano K, Main ML, Saito S. Aonuma K, et al. Among authors: takayama m. Circ J. 2018 Nov 24;82(12):2946-2953. doi: 10.1253/circj.CJ-18-0222. Epub 2018 Oct 11. Circ J. 2018. PMID: 30305484 Free article. Clinical Trial.
Efficacy and Safety of Left Atrial Appendage Closure With WATCHMAN in Japanese Nonvalvular Atrial Fibrillation Patients　- Final 2-Year Follow-up Outcome Data From the SALUTE Trial.
Aonuma K, Yamasaki H, Nakamura M, Matsumoto T, Takayama M, Ando K, Hirao K, Goya M, Morino Y, Hayashida K, Kusano K, Gomi Y, Main ML, Uchida T, Saito S. Aonuma K, et al. Among authors: takayama m. Circ J. 2020 Jul 22;84(8):1237-1243. doi: 10.1253/circj.CJ-20-0196. Epub 2020 Jun 26. Circ J. 2020. PMID: 32595176 Free article. Clinical Trial.
AVJ-514 Trial　- Baseline Characteristics and 30-Day Outcomes Following MitraClip® Treatment in a Japanese Cohort.
Hayashida K, Yasuda S, Matsumoto T, Amaki M, Mizuno S, Tobaru T, Jujo K, Ootomo T, Yamaguchi J, Fukuda K, Saito S, Foster E, Qasim A, Kitakaze M, Yozu R, Takayama M. Hayashida K, et al. Among authors: takayama m. Circ J. 2017 Jul 25;81(8):1116-1122. doi: 10.1253/circj.CJ-17-0115. Epub 2017 Mar 17. Circ J. 2017. PMID: 28321004 Free article. Clinical Trial.
Contemporary Antiplatelet Therapy and Clinical Outcomes of Japanese Patients With Acute Myocardial Infarction　- Results From the Prospective Japan Acute Myocardial Infarction Registry (JAMIR).
Yasuda S, Honda S, Takegami M, Nishihira K, Kojima S, Asaumi Y, Suzuki M, Kosuge M, Takahashi J, Sakata Y, Takayama M, Sumiyoshi T, Ogawa H, Kimura K; JAMIR Investigators. Yasuda S, et al. Among authors: takayama m. Circ J. 2019 Jul 25;83(8):1633-1643. doi: 10.1253/circj.CJ-19-0145. Epub 2019 Jun 14. Circ J. 2019. PMID: 31204353 Free article.
A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J'xactly Study).
Okumura Y, Fukuda I, Nakamura M, Yamada N, Takayama M, Maeda H, Yamashita T, Ikeda T, Mo M, Kobayashi T, Niwa A, Matsuo H, Yokoi H, Koga M, Yamazaki T, Hirayama A; J’xactly Investigators. Okumura Y, et al. Among authors: takayama m. Circ J. 2020 Oct 23;84(11):1912-1921. doi: 10.1253/circj.CJ-20-0636. Epub 2020 Sep 26. Circ J. 2020. PMID: 32981924 Free article.
912 results